Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 83
- +16 vs. Q2 2025
- Portfolio value
- $1.31B
- +$313.4M (+31.6%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UTHRUnited Therapeutics Corp | COM | 253,220 | $106.2M | 8.1% | +193,854+326.5% | Added | History |
| GSKGSK plc | ADR | 2,120,446 | $91.5M | 7.0% | −121,942−5.4% | Reduced | History |
| NTRANatera, Inc. | COM | 519,644 | $83.6M | 6.4% | −276,731−34.7% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 2,807,836 | $81.6M | 6.2% | +424,781+17.8% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 3,467,314 | $53.3M | 4.1% | −598,041−14.7% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 1,421,983 | $51.2M | 3.9% | +123,469+9.5% | Added | History |
| QUREuniQure N.V. | SHS | 877,373 | $51.2M | 3.9% | +877,373 | New | History |
| HCAHCA Healthcare, Inc. | COM | 111,700 | $47.6M | 3.6% | +11,717+11.7% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,924,306 | $41.5M | 3.2% | +21,767+1.1% | Added | History |
| ZIMVZimVie Inc. | Stock | 2,079,380 | $39.4M | 3.0% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 426,499 | $36.2M | 2.8% | +426,499 | New | History |
| IONSIonis Pharmaceuticals Inc | COM | 538,661 | $35.2M | 2.7% | −50,239−8.5% | Reduced | History |
| RVTYRevvity, Inc. | COM | 394,311 | $34.6M | 2.6% | −116,019−22.7% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 1,417,204 | $33.9M | 2.6% | +102,171+7.8% | Added | History |
| TECHBIO-TECHNE Corp | COM | 591,540 | $32.9M | 2.5% | +197,401+50.1% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,153,920 | $29.9M | 2.3% | +315,184+37.6% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,363,653 | $27.5M | 2.1% | +310,772+29.5% | Added | History |
| BRKRBruker Corp | COM | 687,129 | $22.3M | 1.7% | −152,155−18.1% | Reduced | History |
| CYHCommunity Health Systems Inc | COM | 6,950,051 | $22.3M | 1.7% | +805,667+13.1% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 62,820 | $21.7M | 1.7% | +2,084+3.4% | Added | History |
| DHRDanaher Corp | Stock | 99,273 | $19.7M | 1.5% | +75,824+323.4% | Added | History |
| GERNGeron Corp | COM | 12,599,002 | $17.3M | 1.3% | +5,278,828+72.1% | Added | History |
| ELVElevance Health, Inc. | Stock | 44,980 | $14.5M | 1.1% | +26,018+137.2% | Added | History |
| PODDInsulet Corp | Stock | 45,604 | $14.1M | 1.1% | +45,604 | New | History |
| RGENRepligen Corp | COM | 105,087 | $14.0M | 1.1% | +86,467+464.4% | Added | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 488,592 | $13.9M | 1.1% | +74,162+17.9% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 302,911 | $13.2M | 1.0% | +302,911 | New | – |
| NVONovo Nordisk A S | ADR | 217,708 | $12.1M | 0.9% | +217,708 | New | History |
| ILMNIllumina, Inc. | COM | 123,674 | $11.7M | 0.9% | −74,910−37.7% | Reduced | History |
| AVTRAvantor, Inc. | COM | 924,442 | $11.5M | 0.9% | −601,722−39.4% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 486,021 | $11.1M | 0.8% | +127,193+35.4% | Added | History |
| MNKDMannkind Corp | COM NEW | 2,042,727 | $11.0M | 0.8% | +1,345,017+192.8% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,373,625 | $10.4M | 0.8% | +165,987+13.7% | Added | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 976,511 | $9.81M | 0.8% | +976,511 | New | History |
| ICLRIcon PLC | COM | 55,025 | $9.63M | 0.7% | −9,562−14.8% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 16,720 | $9.40M | 0.7% | +3,466+26.2% | Added | History |
| EOLSEvolus, Inc. | COM | 1,475,109 | $9.06M | 0.7% | +304,798+26.0% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 502,234 | $8.15M | 0.6% | +109,495+27.9% | Added | History |
| CNCCentene Corp | Stock | 224,550 | $8.01M | 0.6% | −174,176−43.7% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 146,642 | $7.94M | 0.6% | +146,642 | New | History |
| ARDXArdelyx, Inc. | COM | 1,429,377 | $7.88M | 0.6% | +1,429,377 | New | History |
| BIIBBiogen Inc. | COM | 51,765 | $7.25M | 0.6% | +51,765 | New | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 350,812 | $6.91M | 0.5% | +350,812 | New | History |
| DVAXDynavax Technologies Corp | COM NEW | 693,527 | $6.89M | 0.5% | −503,662−42.1% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 14,426 | $6.45M | 0.5% | +14,426 | New | History |
| ETNB89bio, Inc. | COM | 392,441 | $5.77M | 0.4% | +156,451+66.3% | Added | History |
| HQYHealthequity, Inc. | COM | 52,388 | $4.96M | 0.4% | −103,480−66.4% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 166,391 | $4.66M | 0.4% | +67,053+67.5% | Added | History |
| MRUSMerus N.V. | COM | 48,054 | $4.52M | 0.3% | −82,870−63.3% | Reduced | History |
| ALECAlector, Inc. | COM | 1,488,725 | $4.41M | 0.3% | −497,347−25.0% | Reduced | History |
| HUMHumana Inc | Stock | 16,652 | $4.33M | 0.3% | −26,968−61.8% | Reduced | History |
| RAPPRapport Therapeutics, Inc. | COM | 143,565 | $4.26M | 0.3% | +143,565 | New | History |
| TYRATyra Biosciences, Inc. | COM | 272,706 | $3.82M | 0.3% | +272,706 | New | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 49,314 | $3.62M | 0.3% | −182,861−78.8% | Reduced | History |
| ZBIOZenas BioPharma, Inc. | COM | 158,742 | $3.52M | 0.3% | −166,737−51.2% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 164,237 | $3.50M | 0.3% | +164,237 | New | History |
| BVSBioventus Inc. | COM CL A | 433,933 | $2.90M | 0.2% | +433,933 | New | History |
| NKTRNektar Therapeutics | COM NEW | 49,890 | $2.84M | 0.2% | −65,110−56.6% | Reduced | History |
| AMRNAmarin Corp PLC | SPONSORED ADR | 167,276 | $2.74M | 0.2% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 479,056 | $2.50M | 0.2% | −54,353−10.2% | Reduced | History |
| GOSSGossamer Bio, Inc. | COM | 925,233 | $2.43M | 0.2% | −770,529−45.4% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 263,628 | $2.33M | 0.2% | +263,628 | New | History |
| IFRXInflaRx N.V. | COM | 1,730,635 | $2.32M | 0.2% | +90,205+5.5% | Added | History |
| IVVDInvivyd, Inc. | COM | 2,047,265 | $2.25M | 0.2% | +2,047,265 | New | History |
| AVRAnteris Technologies Global Corp. | COM | 500,000 | $2.25M | 0.2% | +500,000 | New | History |
| NVAXNovavax Inc | COM NEW | 243,184 | $2.11M | 0.2% | +243,184 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 111,466 | $2.10M | 0.2% | +111,466 | New | History |
| STROSutro Biopharma, Inc. | COM | 2,291,313 | $1.99M | 0.2% | −9480.0% | Reduced | History |
| FTREFortrea Holdings Inc. | COMMON STOCK | 219,384 | $1.85M | 0.1% | 00.0% | Unchanged | History |
| MOHMolina Healthcare, Inc. | COM | 9,470 | $1.81M | 0.1% | −11,130−54.0% | Reduced | History |
| CTNMContineum Therapeutics, Inc. | CL A | 134,619 | $1.58M | 0.1% | +134,619 | New | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 194,440 | $1.50M | 0.1% | −17,029−8.1% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 824,594 | $1.22M | 0.1% | +824,594 | New | History |
| KRROKorro Bio, Inc. | COM | 20,856 | $998.8K | 0.1% | +20,856 | New | History |
| SRZNSurrozen, Inc. | COM NEW | 76,997 | $992.1K | 0.1% | +76,997 | New | History |
| PNTGPennant Group, Inc. | COM | 37,980 | $957.9K | 0.1% | 00.0% | Unchanged | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 290,673 | $834.2K | 0.1% | −350,000−54.6% | Reduced | History |
| PVLAPalvella Therapeutics, Inc. | COM | 11,343 | $711.1K | 0.1% | +11,343 | New | History |
| EHTHeHealth, Inc. | COM | 128,322 | $553.1K | <0.1% | 00.0% | Unchanged | History |
| RVPRetractable Technologies Inc | COM | 363,315 | $305.9K | <0.1% | +363,315 | New | History |
| REPLReplimune Group, Inc. | COM | 59,992 | $251.4K | <0.1% | +59,992 | New | History |
| CBLLCeribell, Inc. | COM | 17,094 | $196.4K | <0.1% | +17,094 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 10,000 | $126.5K | <0.1% | +10,000 | New | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2025 (13)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| INSPInspire Medical Systems, Inc. | COM | 164,473 | $21.3M | 2.2% | History |
| IQVIQVIA Holdings Inc. | Stock | 97,604 | $15.4M | 1.6% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 277,316 | $15.3M | 1.5% | History |
| GMEDGlobus Medical Inc | Stock | 169,643 | $10.0M | 1.0% | History |
| TMOThermo Fisher Scientific Inc. | Stock | 13,685 | $5.55M | 0.6% | History |
| GKOSGLAUKOS Corp | COM | 31,496 | $3.25M | 0.3% | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 610,231 | $1.39M | 0.1% | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 257,154 | $1.11M | 0.1% | History |
| ITOSiTeos Therapeutics, Inc. | COM | 109,324 | $1.09M | 0.1% | History |
| PBYIPuma Biotechnology, Inc. | COM | 240,688 | $825.6K | 0.1% | History |
| ARCTArcturus Therapeutics Holdings Inc. | COM | 48,364 | $629.2K | 0.1% | History |
| MODVModivCare Inc | COM | 100,000 | $312.0K | <0.1% | History |
| ACIUAC Immune SA | SHS | 100,752 | $204.5K | <0.1% | History |